AlphaFold predicted structure
CCNK · O75909

Mean pLDDT
65.1/ 100
Low
580 residues
Confidence breakdown
- Very high(≥ 90)40%
- Confident(70–90)2%
- Low(50–70)11%
- Very low(< 50)47%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
cyclin K
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Intellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownHIV infectious disease
intellectual developmental disorder with hypertelorism and distinctive facies
neurodegenerative disease
cancer
lung cancer
lung carcinoma
breast carcinoma
breast cancer
neoplasm
endometrial cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Cyclin-K
Regulatory subunit of cyclin-dependent kinases that mediates activation of target kinases. Plays a role in transcriptional regulation via its role in regulating the phosphorylation of the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A)
CCNK · O75909

Mean pLDDT
65.1/ 100
Low
580 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0